Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients
about
Ciliary neurotrophic factor (CNTF) for amyotrophic lateral sclerosis or motor neuron diseaseCiliary neurotrophic factor for amyotrophic lateral sclerosis/motor neuron diseaseCLF associates with CLC to form a functional heteromeric ligand for the CNTF receptor complexThe ciliary neurotrophic factor receptor alpha component induces the secretion of and is required for functional responses to cardiotrophin-like cytokineNeuroprotection, Growth Factors and BDNF-TrkB Signalling in Retinal DegenerationArtificial cell bioencapsulation in macro, micro, nano, and molecular dimensions: keynote lectureGrafts of adenosine-releasing cells suppress seizures in kindling epilepsyReducing amyloid plaque burden via ex vivo gene delivery of an Abeta-degrading protease: a novel therapeutic approach to Alzheimer disease.Artificial cells, encapsulation, and immobilization.Encapsulation for somatic gene therapy.Genetic regulatory elements introduced into neural stem and progenitor cell populations.The behavioral and biochemical effects of BDNF containing polymers implanted in the hippocampus of rats.Gene therapy in the CNS.Chronic delivery of antibody fragments using immunoisolated cell implants as a passive vaccination toolIntracerebroventricular injection of encapsulated human mesenchymal cells producing glucagon-like peptide 1 prolongs survival in a mouse model of ALS.Therapeutic developments in the treatment of amyotrophic lateral sclerosis.Motor neuron trophic factors: therapeutic use in ALS?Intravitreous transplantation of encapsulated fibroblasts secreting the human fibroblast growth factor 2 delays photoreceptor cell degeneration in Royal College of Surgeons rats.Cellular implants: pioneers in xenotransplantation?Gene therapy in autoimmune, demyelinating disease of the central nervous system.Artificial cells for replacement of metabolic organ functions.Progress and challenges for cell encapsulation in brain tumour therapy.Continued administration of ciliary neurotrophic factor protects mice from inflammatory pathology in experimental autoimmune encephalomyelitis.Artificial cells for cell and organ replacements.Encapsulated cellular implants for recombinant protein delivery and therapeutic modulation of the immune system.History of xenotransplantation.Cell therapy in Huntington's disease.Therapeutic applications of polymeric artificial cells.Recent advances in amyotrophic lateral sclerosis research: perspectives for personalized clinical applicationThe neuroprotective agent CNTF decreases neuronal metabolites in the rat striatum: an in vivo multimodal magnetic resonance imaging study.Sodium Benzoate, a Metabolite of Cinnamon and a Food Additive, Upregulates Ciliary Neurotrophic Factor in Astrocytes and Oligodendrocytes.Intraparenchymal spinal cord delivery of adeno-associated virus IGF-1 is protective in the SOD1G93A model of ALSNeurotrophic factors in neurodegeneration.Targeted axonal import (TAxI) peptide delivers functional proteins into spinal cord motor neurons after peripheral administration.Neurodegeneration and cell replacement.Up-regulation of ciliary neurotrophic factor in astrocytes by aspirin: implications for remyelination in multiple sclerosis.Challenges and emerging technologies in the immunoisolation of cells and tissues.The role of neurotrophic factors in the pathology and treatment of multiple sclerosis.Growth factor-expressing human neural progenitor cell grafts protect motor neurons but do not ameliorate motor performance and survival in ALS mice.Nano to micro delivery systems: targeting angiogenesis in brain tumors.
P2860
P921
Q24246738-063DB9BD-CBC9-4E37-8B6D-57272F45A59DQ24250079-FBE79273-5449-48D0-B71C-EFFAB8DE687BQ24290161-12090F17-6878-48E2-9C60-E5FF5A881CDFQ24291080-58DDECCB-EB8B-4561-8FBD-DEF5F6275DBFQ28069477-E6BA2244-14AB-4D0D-B591-89A4AB07E88FQ28251032-7E7783F0-3BEC-49AD-BED4-E4024E18491AQ28366761-9D30D610-A78E-43FF-BEFD-04B76D400CFEQ30833707-E030C73B-C005-47BC-8FC8-71232247EE8CQ33692517-5820DB42-6BDA-4FD5-A763-B28FDD183015Q33692528-673790D4-FA35-443C-8420-8C214378D5A3Q33693779-753CCA0F-2A7B-459B-BA6B-E238C01328CAQ33712487-AEC6E83A-027C-4F06-A60F-D38FA113B0C6Q33837123-84364551-7A56-46A7-8EF1-99716468BD75Q33886377-18CF656B-E483-4A9E-9217-DF3B1B0A5BA6Q34321059-10E71A1E-8D58-4BD1-8E2A-A944C50EB0CBQ34974850-108E385B-AF5F-4423-9187-95FEFA2F7773Q35027903-86950EFF-A936-4486-8E2A-D6FDB4C2004CQ35067026-D311167F-C4B6-4C1B-9E0A-B82F41A592EFQ35067196-5C8C7F95-F6F4-4268-B327-00D54E1FD38CQ35122159-84B77396-34F6-4AE0-9BC8-91E766E87EC5Q35129286-37FF5F50-512D-4BF1-B44B-2DAA35BB51B6Q35164781-0CAC2C69-BE6D-4C26-8776-2BF340F8EF02Q35221952-39E6A7C1-9BF0-423E-8FEF-162AE66D8617Q35717682-D400ED00-0F65-4846-870A-B321FC848CB1Q35723422-1EB5C368-A179-435C-99D8-A2CFDFE7CDC0Q36031618-8B81F26A-4531-4170-A574-657516823B08Q36045364-A89F17C2-0668-40C5-A8A7-2CFF1BA8F652Q36058455-4E53B0E0-A983-4D2A-884A-3A75763F606FQ36117618-CE4895C2-4CDD-47A6-A5C8-F5FC44C7FF94Q36267231-15324C5B-D1B8-48C8-8DC6-BA156406EE5FQ36277686-6653472F-21B9-47F9-ADFC-95127D43F608Q36491424-A9DFD113-051E-4D10-80B2-B96679ACB0ABQ36654492-BD8B4401-9285-4DD6-B8C2-B6B27CDC9A73Q36658903-5C4CF739-6BD9-420B-9A56-CFB137896E0BQ36748869-E1F2DE1E-B881-4FB0-9E2B-D7BD1B9E079BQ36947884-88644BDD-1301-4FFC-BAAA-53824A4588F4Q37006047-EF349BC8-A9F6-4017-A004-0D3D69CB03B9Q37269263-893553B6-46FA-4568-AB75-F05E88853B6DQ37290026-DFBEAB6F-DD7A-46DD-8CA6-F46419F3BCAAQ37798870-E892A708-55B1-452A-AD11-7B11B0F9A246
P2860
Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients
description
1996 nî lūn-bûn
@nan
1996 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Intrathecal delivery of CNTF u ...... hic lateral sclerosis patients
@ast
Intrathecal delivery of CNTF u ...... hic lateral sclerosis patients
@en
Intrathecal delivery of CNTF u ...... hic lateral sclerosis patients
@nl
type
label
Intrathecal delivery of CNTF u ...... hic lateral sclerosis patients
@ast
Intrathecal delivery of CNTF u ...... hic lateral sclerosis patients
@en
Intrathecal delivery of CNTF u ...... hic lateral sclerosis patients
@nl
prefLabel
Intrathecal delivery of CNTF u ...... hic lateral sclerosis patients
@ast
Intrathecal delivery of CNTF u ...... hic lateral sclerosis patients
@en
Intrathecal delivery of CNTF u ...... hic lateral sclerosis patients
@nl
P2093
P2860
P3181
P356
P1433
P1476
Intrathecal delivery of CNTF u ...... hic lateral sclerosis patients
@en
P2093
E E Baetge
J M Joseph
J P Hammang
P Aebischer
P2507
P2860
P2888
P3181
P356
10.1038/NM0696-696
P407
P577
1996-06-01T00:00:00Z